Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.

Wong, R J; Liu, B; Bhuket, T

Wong, R J; Liu, B; Bhuket, T.

Affiliation

Wong RJ; Division of Gastroenterology and Hepatology, Alameda Health System, Highland Hospital, Oakland, CA, USA.
Liu B; Division of Gastroenterology and Hepatology, Alameda Health System, Highland Hospital, Oakland, CA, USA.
Bhuket T; Division of Gastroenterology and Hepatology, Alameda Health System, Highland Hospital, Oakland, CA, USA.

Aliment Pharmacol Ther ; 46(10): 974-980, 2017 11.

Article de En | MEDLINE | ID: mdl-28914448

Sujet(s)
Mots clés

NAFLD; NASH; chronic liver disease; cirrhosis: NHANES

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Coûts indirects de la maladie / Stéatose hépatique non alcoolique / Cirrhose du foie Type d'étude: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Aliment Pharmacol Ther Sujet du journal: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Année: 2017 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google